Receiving-site gap assessmentQuality agreement reviewFirst-lot release records
Home / Analytical Method Transfer Evidence for Peptide Buyers

Analytical Method Transfer Evidence for Peptide Buyers

Assess whether a receiving laboratory can interpret the agreed measurement and report it on the correct basis.

What analytical question must the receiver answer?

Identify the attribute, method identifier, reporting unit and intended purpose in the existing specification. Ask the sending laboratory which evidence establishes that the method is suitable for that purpose and what access the receiver will have to it. ICH Q2(R2) discusses analytical procedure validation. A validation document can be relevant background, while the transfer review still needs to address how the receiving organisation will report the agreed attribute.

ICH / FDA (2024) · Q2(R2) Validation of Analytical Procedures

A liquid chromatography instrument and a separate mass spectrometer share a laboratory work area.
Chromatography and mass spectrometry instrumentationThe reference instrument photograph gives context for the identity report requested from the actual testing laboratory.
Image creditsSarka Na kopci · Image source · CC BY-SA 4.0 · Converted to WebP.
Rows of cartons are stacked on pallets in the UNICEF warehouse in Copenhagen.
Palletised shipping cartonsPallets, outer cases and inner units are different levels to record when reconciling a shipment.
Image creditsheb (Wikimedia Commons) · Image source · CC BY-SA 3.0 · Converted to WebP.

What constitutes an interpretable comparison?

Agree how each laboratory will identify the relevant material, reference and report version. Record the pre-agreed comparison question, decision criteria and person authorised to interpret differences. Ask the parties to specify whether summaries, individual results or underlying records will be available to the buyer. Where two reports use different amount bases or naming conventions, keep the difference visible until the laboratories confirm what can be compared.

WHO (2022) · Technology transfer in pharmaceutical manufacturing, TRS 1044 Annex 4

How should conflicting conclusions be reported?

Suppose the receiving laboratory flags a sample while the sending laboratory describes it as acceptable. Check the material identity, method revision and reporting convention before drawing a conclusion. Keep both original reports, assign a joint review owner and distinguish an unexplained discrepancy from a confirmed result outside the applicable specification. If the latter is established, the responsible quality team should follow the applicable investigation process. The procurement record should show the open decision and its effect on handover.

FDA (2022) · Investigating out-of-specification pharmaceutical test results

Worked example

If the parties use different decimal conventions in their report templates, ask for a worked administrative example using dummy values. Have both reviewers confirm that the exported summary preserves the intended precision and units. Record the agreed presentation in the handover documentation.

Prepare your inquiry

A comparison requires agreement on the measured attribute, sample, reporting basis and decision criteria.

Select the items you want to ask about.

Certificates of analysis

For a transferred lyophilized powder project, compare the issuing site, lot identifier and certificate version with the agreed first-lot release record.

Read a COA